Clinical Trials Directory

Trials / Completed

CompletedNCT00374530

Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Before, during and after intravenous administration of PGE2 we score/measure headache, rCBF, blood flow in the middle cerebral artery and diameter of superficial temporal artery and correlate that to known pathophysiology of headache to see if PGE2 is involved in headache pathophysiology.

Conditions

Interventions

TypeNameDescription
DRUGPGE2

Timeline

Start date
2006-08-01
First posted
2006-09-11
Last updated
2007-08-01

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00374530. Inclusion in this directory is not an endorsement.